$STAA
STAAR Surgical Co Stock $staa

$staa Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000114420415029817 Filed on May 12, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$18.86M	$20.18M
YoY Change	-6.54%	11.09%
Cost Of Revenue	$5.960M	$6.294M
YoY Change	-5.31%	13.53%
Gross Profit	$12.90M	$13.88M
YoY Change	-7.09%	10.02%
Gross Profit Margin	68.4%	68.81%
Selling, General & Admin	$10.78M	$11.53M
YoY Change	-6.54%	20.37%
% of Gross Profit	83.57%	83.07%
Research & Development	$3.580M	$3.484M
YoY Change	2.76%	106.64%
% of Gross Profit	27.75%	25.09%
Depreciation & Amortization	$497.0K	$453.0K
YoY Change	9.71%	-21.9%
% of Gross Profit	3.85%	3.26%
Operating Expenses	$14.41M	$15.02M
YoY Change	-4.05%	33.28%
Operating Profit	-$1.511M	-$1.342M
YoY Change	12.59%	-293.37%
Interest Expense	-$930.0K	$33.00K
YoY Change	-2918.18%	-19.51%
% of Operating Profit
Other Income/Expense, Net	$70.00K	$202.0K
YoY Change	-65.35%	10.38%
Pretax Income	-$2.370M	-$1.140M
YoY Change	107.89%	-229.99%
Income Tax	-$30.00K	$219.0K
% Of Pretax Income
Net Earnings	-$2.340M	-$1.359M
YoY Change	72.19%	-588.85%
Net Earnings / Revenue	-12.41%	-6.74%
Basic Earnings Per Share		-$0.04
Diluted Earnings Per Share	-$60.81K	-$0.04
COMMON SHARES
Basic Shares Outstanding	38.48M shares	37.79M shares
Diluted Shares Outstanding		37.79M shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.80M	$21.10M
YoY Change	-48.82%	7.11%
Cash & Equivalents	$10.81M	$21.07M
Short-Term Investments
Other Short-Term Assets	$364.0K	$989.0K
YoY Change	-63.2%	70.81%
Inventory	$15.30M	$13.80M
Prepaid Expenses	$2.835M	$2.820M
Receivables	$11.00M	$11.10M
Other Receivables	$1.600M	$700.0K
Total Short-Term Assets	$43.00M	$51.10M
YoY Change	-15.85%	16.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.900M	$8.800M
YoY Change	12.5%	43.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.300M	$1.300M
YoY Change	0.0%	24.88%
Total Long-Term Assets	$13.80M	$13.20M
YoY Change	4.55%	21.64%
TOTAL ASSETS
Total Short-Term Assets	$43.00M	$51.10M
Total Long-Term Assets	$13.80M	$13.20M
Total Assets	$56.80M	$64.30M
YoY Change	-11.66%	17.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.900M	$6.200M
YoY Change	-20.97%	62.77%
Accrued Expenses	$3.700M	$4.900M
YoY Change	-24.49%	32.43%
Deferred Revenue
YoY Change
Short-Term Debt	$4.200M	$4.800M
YoY Change	-12.5%	-5.88%
Long-Term Debt Due	$300.0K	$300.0K
YoY Change	0.0%	-40.0%
Total Short-Term Liabilities	$15.00M	$18.30M
YoY Change	-18.03%	18.68%
LONG-TERM LIABILITIES
Long-Term Debt	$400.0K	$100.0K
YoY Change	300.0%	-66.67%
Other Long-Term Liabilities	$3.200M	$2.900M
YoY Change	10.34%	-12.12%
Total Long-Term Liabilities	$3.600M	$3.000M
YoY Change	20.0%	-16.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.00M	$18.30M
Total Long-Term Liabilities	$3.600M	$3.000M
Total Liabilities	$20.50M	$23.10M
YoY Change	-11.26%	15.47%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$36.30M	$41.30M
YoY Change
Total Liabilities & Shareholders Equity	$56.80M	$64.30M
YoY Change	-11.66%	17.62%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$2.340M	-$1.359M
YoY Change	72.19%	-588.85%
Depreciation, Depletion And Amortization	$497.0K	$453.0K
YoY Change	9.71%	-21.9%
Cash From Operating Activities	-$2.210M	-$2.590M
YoY Change	-14.67%	-427.85%
INVESTING ACTIVITIES
Capital Expenditures	$328.0K	$1.414M
YoY Change	-76.8%	-276.75%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$330.0K	-$1.410M
YoY Change	-76.6%	76.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	310.0K	2.140M
YoY Change	-85.51%	210.14%
NET CHANGE
Cash From Operating Activities	-2.210M	-2.590M
Cash From Investing Activities	-330.0K	-1.410M
Cash From Financing Activities	310.0K	2.140M
Net Change In Cash	-2.230M	-1.860M
YoY Change	19.89%	-373.53%
FREE CASH FLOW
Cash From Operating Activities	-$2.210M	-$2.590M
Capital Expenditures	$328.0K	$1.414M
Free Cash Flow	-$2.538M	-$4.004M
YoY Change	-36.61%	-351.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	194000	USD
CY2015Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	309000	USD
CY2015Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	179000	USD
CY2015Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	550000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13013000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11054000	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	15717000	USD
CY2015Q1	staa	Prepaid Expenses Deposits And Other Assets Current PrepaidExpensesDepositsAndOtherAssetsCurrent	4517000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	596000	USD
CY2015Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	600000	USD
CY2015Q2	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Prior Year Reclassifications</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain reclassifications have been made to the prior periods’ unaudited condensed financial statements and related note disclosures to conform to current period’s presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1589000	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1688000	USD
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38429000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38790000	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38429000	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38790000	shares
CY2015Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2146000	USD
CY2015Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2078000	USD
CY2015Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1781000	USD
CY2015Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1881000	USD
CY2015Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14504000	USD
CY2015Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14115000	USD
CY2015Q1	us-gaap	Inventory Gross InventoryGross	18431000	USD
CY2015Q2	us-gaap	Inventory Gross InventoryGross	18074000	USD
CY2015Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2714000	USD
CY2015Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2801000	USD
CY2015Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1991000	USD
CY2015Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2835000	USD
CY2015Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	721000	USD
CY2015Q2	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	622000	USD
CY2015Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	338000	USD
CY2015Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	483000	USD
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	383000	USD
CY2015Q2	us-gaap	Other Assets Current OtherAssetsCurrent	364000	USD
CY2015Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	15674000	USD
CY2015Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	15969000	USD
CY2015Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	6535000	USD
CY2015Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	6540000	USD
CY2015Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	8400000	USD
CY2015Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	8413000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30609000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30922000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20543000	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20999000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11352000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10528000	USD
CY2015Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1647000	USD
CY2015Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2050000	USD
CY2015Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	75000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1578000	USD
CY2015Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	553000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	867000	USD
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	204000	USD
CY2015Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	352000	USD
CY2015Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	677000	USD
CY2015Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	990000	USD
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1197000	USD
CY2015Q2	staa	Percentage Of Other Current Liabilities PercentageOfOtherCurrentLiabilities	0.05	pure
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-2340000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	38638000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	-157000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38481000	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37794000	shares
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	20178000	USD
CY2014Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6294000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	13884000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5396000	USD
CY2014Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6138000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3484000	USD
CY2014Q2	staa	Medical Device Tax MedicalDeviceTax	40000	USD
CY2014Q2	us-gaap	Other General Expense OtherGeneralExpense	168000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1342000	USD
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	33000	USD
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	66000	USD
CY2014Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	160000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	202000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1140000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	219000	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2798000	shares
CY2015Q2	us-gaap	Entity Wide Disclosure On Geographic Areas Description Of Revenue From External Customers EntityWideDisclosureOnGeographicAreasDescriptionOfRevenueFromExternalCustomers	The Company markets and sells its products in over 60 countries and has manufacturing sites in the United States and Switzerland. Other than the United States, Japan, Korea, China, Spain, and France, the Company does not conduct business in any country in which its sales exceed 5% of consolidated net sales.
CY2015Q2	staa	Segment Sales To Consolidated Sales Percentage SegmentSalesToConsolidatedSalesPercentage	1	pure
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	1500000	USD
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	994000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5525	pure
CY2014Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	35000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	27000	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1740000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5746	pure
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0128	pure
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0170	pure
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M13D
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y7M20D
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3175000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	568000	shares
CY2015Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	104000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	19000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3620000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2384000	shares
CY2015Q2	staa	Estimated Forfeiture Rate EstimatedForfeitureRate	0.0692	pure
CY2015Q2	staa	Warrants And Rights Exercisable WarrantsAndRightsExercisable	700000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	700000	shares
CY2014Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets Period Increase Decrease DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease	-11000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets Period Increase Decrease DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease	-8000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-6000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-15000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	11000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	79000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	62000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1357000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2278000	USD
CY2014Q2	us-gaap	Depreciation Depreciation	453000	USD
CY2015Q2	us-gaap	Depreciation Depreciation	497000	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	106000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52000	USD
CY2014Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	24000	USD
CY2015Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-118000	USD
CY2014Q2	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	45000	USD
CY2015Q2	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	50000	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1500000	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	994000	USD
CY2014Q2	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	1000	USD
CY2015Q2	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	1000	USD
CY2014Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-55000	USD
CY2015Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	99000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	295000	USD
CY2015Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	56000	USD
CY2014Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1137000	USD
CY2015Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-617000	USD
CY2014Q2	staa	Increase Decrease In Prepaid Expenses Deposits And Other Assets Current IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssetsCurrent	1270000	USD
CY2015Q2	staa	Increase Decrease In Prepaid Expenses Deposits And Other Assets Current IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssetsCurrent	573000	USD
CY2014Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-610000	USD
CY2015Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1741000	USD
CY2014Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3000	USD
CY2015Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	309000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2594000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2209000	USD
CY2014Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1414000	USD
CY2015Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	328000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1414000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-326000	USD
CY2014Q2	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	46000	USD
CY2015Q2	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	115000	USD
CY2014Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2188000	USD
CY2015Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	421000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2142000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	306000	USD
CY2014Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-18000	USD
CY2015Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	25000	USD
CY2015Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1084000	USD
CY2015Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	967000	USD
CY2015Q2	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	230000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1884000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2204000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22954000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21070000	USD
CY2015Q1	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	186000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	4000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	24000	USD
CY2014Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2015Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	116000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	107000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	19000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	21000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	130000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	120000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-6000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-12000	USD
CY2014Q2	us-gaap	Defined Benefit Plan Amortization Of Transition Obligations Assets DefinedBenefitPlanAmortizationOfTransitionObligationsAssets	0	USD
CY2015Q2	us-gaap	Defined Benefit Plan Amortization Of Transition Obligations Assets DefinedBenefitPlanAmortizationOfTransitionObligationsAssets	3000	USD
CY2015Q2	staa	Compensation Cost Capitalised CompensationCostCapitalised	122000	USD
CY2014Q2	staa	Compensation Cost Capitalised CompensationCostCapitalised	78000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1116000	USD

Files In Submission

Name	View Source	Status
0001144204-15-029817-index-headers.html	Edgar Link	pending
0001144204-15-029817-index.html	Edgar Link	pending
0001144204-15-029817.txt	Edgar Link	pending
0001144204-15-029817-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
staa-20150403.xml	Edgar Link	completed
staa-20150403.xsd	Edgar Link	pending
staa-20150403_cal.xml	Edgar Link	unprocessable
staa-20150403_def.xml	Edgar Link	unprocessable
staa-20150403_lab.xml	Edgar Link	unprocessable
staa-20150403_pre.xml	Edgar Link	unprocessable
v409477_10q.htm	Edgar Link	pending
v409477_ex31-1.htm	Edgar Link	pending
v409477_ex31-2.htm	Edgar Link	pending
v409477_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STAA
STAAR Surgical Co Stock $staa

2015 Q2 Form 10-Q Financial Statement

#000114420415029817 Filed on May 12, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STAA STAAR Surgical Co Stock $staa

2015 Q2 Form 10-Q Financial Statement

#000114420415029817 Filed on May 12, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STAA
STAAR Surgical Co Stock $staa